| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1325 | Cefazolin | First-generation cephalosporin antibiotic and interleukin 15 inhibitor, specifically interacting with interleukin 15 (IL-15) receptor subunit α (IL-15Rα) and to inhibit IL-15-dependent TNF-α and IL-17 synthesis, showing inhibitory activity against all of |
|
| DCC1326 | Cefmenoxime | Third-generation, semi-synthetic, beta-lactam cephalosporin antibiotic with antibacterial activity |
|
| DCC1327 | Cefonicid | Second-generation, semi-synthetic, beta-lactam cephalosporin antibiotic with antibacterial activity |
|
| DCC1328 | Cefotetan | Broad-spectrum, beta-lactamase-resistant, second-generation cephalosporin antibiotic, inhibiting bacterial cell wall synthesis via inhibition of cross-linking of peptidoglycans |
|
| DCC1329 | Cefotiam | Third-generation broad spectrum antibiotic against both gram-positive and gram-negative microorganisms |
|
| DCC1330 | Cefozopran Hydrochloride | Fourth-generation cephalosporin |
|
| DCC1331 | Cefquinome Sulfate | Broad-spectrum fourth-generation cephalosporin antibiotic |
|
| DCC1332 | Ceftiofur | beta-Lactamase-stable, broad-spectrum, third-generation cephalosporin antibiotic with antibacterial activity |
|
| DCC1333 | Ceftolozane | Broad-spectrum, fifth-generation cephalosporin antibiotic, inactivating penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall |
|
| DCC1334 | Cell Death Modulator Dn1 | Novel modulator of cell death signal transduction pathways, reducing the cytotoxicity of anthrax lethal toxin (LT) |
|
| DCC1335 | Cemmec13 | Novel highly selective TAF1 inhibitor |
|
| DCC1336 | Cep-14083 | Novel potent ALK inhibitor. also inhibiting the insulin receptor |
|
| DCC1337 | Cep-14513 | Novel potent ALK inhibitor |
|
| DCC1338 | Cep-2563 | Prodrug of CEP-751 (KT-6587) as antitumor agent, inhibiting protein kinases |
|
| DCC1339 | Cep-32215 | Novel potent, selective, and orally bioavailable inverse agonist of the histamine H 3 receptor (H 3 R) |
|
| DCC1340 | Cep-8983 | Novel selective inhibitor of the nuclear enzymes poly(ADP-ribose) polymerase (PARP) 1 and 2 |
|
| DCC1341 | Cephaeline | Natural disrupter of RNA G-quadruplexes, inhibiting G-quadruplex-dependent alternative splicing, stimulting the stomach lining and inducing vomiting |
|
| DCC1342 | Ceph-ams | Novel small molecule prodrug for use with SEAKER cells, exhibiting enhanced anticancer activity |
|
| DCC1343 | Cestrin | Novel probe for cellulose synthase trafficking, inhibiting cellulose deposition and interferes with the trafficking of cellulose synthase complexes and their associated proteins KORRIGAN1 and POM2/CSI1 |
|
| DCC1344 | Cf-ahx-lflv-dpp | Novel Probe for the High Temperature Requirement A (HTRA) Serine Proteases |
|
| DCC1345 | Cfg920 | Novel non-steroid reversible dual inhibitor of CYP17 and CYP11B2 against prostate cancer with fewer cardiac side effects |
|
| DCC1346 | Cfi-400936 | Potent inhibitor of TTK kinase |
|
| DCC1347 | Cfi-402257 Hcl | Novel Highly Potent, Selective, Bioavailable TTK (threonine tyrosine kinase) Inhibitor |
|
| DCC1348 | Cg0009 | Novel GSK3 inhibitor, inducing cell death through cyclin D1 depletion in breast cancer cells |
|
| DCC1349 | Cg500354 | Novel inducer of neural differentiation and growth arrest in human primary GBM-derived cells, playing a tumor-suppressive role via cAMP/CREB signaling pathway |
|
| DCC1350 | Cg-707 | Novel PRL-3 inhibitor, blocking the migration and invasion of metastatic cancer cells |
|
| DCC1351 | Cga-jk3 Featured | CGA-JK3 is CGA-JK3 is an ATP-competitive inhibitor of IKKβ-catalyzed kinase activity. CGA-JK3 inhibits IκBα phosphorylation in LPS (HY-D1056) - induced RAW 264.7 cells. |
|
| DCC1352 | C-gboxin | Novel functional Gboxin analogue that is suitable for live-cell ultraviolet crosslink conjugation and click chemistry |
|
| DCC1353 | Cgi-560 | Novel Bruton's tyrosine kinase (BTK) inhibitor |
|
| DCC1354 | Cgk062 | Novel inhibitor of Wnt/β-catenin signaling; Anticancer agent promoting PKCα-mediated β-catenin phosphorylation/degradation |
|
